DK1677772T3 - Oral antidepressiv formulering, der indeholder acetylsalicylsyre, med henblik på acceleration af virkningens indtræden - Google Patents
Oral antidepressiv formulering, der indeholder acetylsalicylsyre, med henblik på acceleration af virkningens indtrædenInfo
- Publication number
- DK1677772T3 DK1677772T3 DK03770801T DK03770801T DK1677772T3 DK 1677772 T3 DK1677772 T3 DK 1677772T3 DK 03770801 T DK03770801 T DK 03770801T DK 03770801 T DK03770801 T DK 03770801T DK 1677772 T3 DK1677772 T3 DK 1677772T3
- Authority
- DK
- Denmark
- Prior art keywords
- acetylsalicylic acid
- onset
- action
- antagonists
- antidepressant
- Prior art date
Links
- 230000001430 anti-depressive effect Effects 0.000 title abstract 5
- 239000000935 antidepressant agent Substances 0.000 title abstract 5
- 229940005513 antidepressants Drugs 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 title abstract 3
- 229960001138 acetylsalicylic acid Drugs 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 title abstract 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 title 1
- 239000005557 antagonist Substances 0.000 abstract 4
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 abstract 2
- BSYNRYMUTXBXSQ-FOQJRBATSA-N 59096-14-9 Chemical class CC(=O)OC1=CC=CC=C1[14C](O)=O BSYNRYMUTXBXSQ-FOQJRBATSA-N 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 229940124834 selective serotonin reuptake inhibitor Drugs 0.000 abstract 1
- 229940076279 serotonin Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/BE2003/000181 WO2005039545A1 (en) | 2003-10-29 | 2003-10-29 | Oral antidepressant formulation comprising acetylsalicylic acid to accelerate onset of action |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1677772T3 true DK1677772T3 (da) | 2009-12-21 |
Family
ID=34468654
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03770801T DK1677772T3 (da) | 2003-10-29 | 2003-10-29 | Oral antidepressiv formulering, der indeholder acetylsalicylsyre, med henblik på acceleration af virkningens indtræden |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1677772B1 (da) |
| JP (1) | JP2007509838A (da) |
| CN (1) | CN1859901A (da) |
| AT (1) | ATE440597T1 (da) |
| AU (1) | AU2003280232A1 (da) |
| BR (1) | BR0318586A (da) |
| CA (1) | CA2543640C (da) |
| CY (1) | CY1110572T1 (da) |
| DE (1) | DE60329034D1 (da) |
| DK (1) | DK1677772T3 (da) |
| EA (1) | EA011926B1 (da) |
| ES (1) | ES2332176T3 (da) |
| PT (1) | PT1677772E (da) |
| SI (1) | SI1677772T1 (da) |
| WO (1) | WO2005039545A1 (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100189797A1 (en) * | 2002-06-10 | 2010-07-29 | Julien Mendlewicz | Oral antidepressant formulation |
| IT1392333B1 (it) * | 2008-12-16 | 2012-02-28 | Giofarma S R L | Preparazione farmaceutica per il trattamento di patologie depressive, contenente una proteina con elevato rapporto triptofano/lnaa |
| GB201002530D0 (en) | 2010-02-15 | 2010-03-31 | Univ Wolverhampton The | Di-aspirin derivatives |
| CN112438991B (zh) * | 2019-08-29 | 2024-03-15 | 鲁南制药集团股份有限公司 | 肝素、或其衍生物、或其可药用盐的医药用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4650789A (en) * | 1985-10-15 | 1987-03-17 | Commonwealth Medical Corporation Of America | Method and composition for increasing production of serotonin |
| GB2287404A (en) * | 1994-03-15 | 1995-09-20 | Pfizer | Antiinflammatory and analgesic compositions |
| DE69905938T2 (de) * | 1998-11-13 | 2003-11-13 | Eli Lilly And Co., Indianapolis | Kombination von duloxetin mit nichtsteroid-entzündungshemmern für die behandlung von schmerz |
| EP1165083A2 (en) * | 1999-04-06 | 2002-01-02 | Sepracor Inc. | Methods and compositions for the treatment of psychotic and related disorders using ziprasidone metabolites |
| US6432989B1 (en) * | 1999-08-27 | 2002-08-13 | Pfizer Inc | Use of CRF antagonists to treat circadian rhythm disorders |
| AU2003229408A1 (en) * | 2002-06-10 | 2003-12-22 | Philippe Kriwin | Oral antidepressant formulation comprising a selective serotonin_reuptake inhibitor |
-
2003
- 2003-10-29 DK DK03770801T patent/DK1677772T3/da active
- 2003-10-29 BR BRPI0318586-9A patent/BR0318586A/pt not_active IP Right Cessation
- 2003-10-29 EA EA200600834A patent/EA011926B1/ru not_active IP Right Cessation
- 2003-10-29 DE DE60329034T patent/DE60329034D1/de not_active Expired - Lifetime
- 2003-10-29 AU AU2003280232A patent/AU2003280232A1/en not_active Abandoned
- 2003-10-29 ES ES03770801T patent/ES2332176T3/es not_active Expired - Lifetime
- 2003-10-29 CA CA2543640A patent/CA2543640C/en not_active Expired - Fee Related
- 2003-10-29 AT AT03770801T patent/ATE440597T1/de active
- 2003-10-29 EP EP03770801A patent/EP1677772B1/en not_active Expired - Lifetime
- 2003-10-29 PT PT03770801T patent/PT1677772E/pt unknown
- 2003-10-29 JP JP2005509765A patent/JP2007509838A/ja active Pending
- 2003-10-29 CN CNA2003801106380A patent/CN1859901A/zh active Pending
- 2003-10-29 WO PCT/BE2003/000181 patent/WO2005039545A1/en not_active Ceased
- 2003-10-29 SI SI200331701T patent/SI1677772T1/sl unknown
-
2009
- 2009-11-26 CY CY20091101244T patent/CY1110572T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE60329034D1 (de) | 2009-10-08 |
| JP2007509838A (ja) | 2007-04-19 |
| EP1677772A1 (en) | 2006-07-12 |
| CN1859901A (zh) | 2006-11-08 |
| CA2543640C (en) | 2010-06-01 |
| BR0318586A (pt) | 2006-10-17 |
| EA200600834A1 (ru) | 2006-10-27 |
| CY1110572T1 (el) | 2015-04-29 |
| AU2003280232A1 (en) | 2005-05-11 |
| ES2332176T3 (es) | 2010-01-28 |
| SI1677772T1 (sl) | 2010-01-29 |
| ATE440597T1 (de) | 2009-09-15 |
| EA011926B1 (ru) | 2009-06-30 |
| CA2543640A1 (en) | 2005-05-06 |
| EP1677772B1 (en) | 2009-08-26 |
| WO2005039545A1 (en) | 2005-05-06 |
| PT1677772E (pt) | 2009-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PA8546601A1 (es) | Nuevos derivados de indol con afinidad por el receptor 5-ht6 | |
| MXPA04000456A (es) | Analogos de prostaglandina como agonistas del receptor ep4. | |
| ATE406360T1 (de) | Antagonisten der opioidrezeptoren | |
| EA200600190A1 (ru) | Производные пиримидин-2,4-диона в качестве антагонистов рецептора гонадотропин-высвобождающего гормона | |
| IS8503A (is) | Azatvíhringja heteróhringir sem kannabínóníð-viðtakastillar | |
| NO20032905D0 (no) | Nye benzodiazepiner og beslektede heterocykliske derivater som er anvendelige som orexinreseptorantagonister | |
| UY28026A1 (es) | 4-piperazinilbencenosulfonilindoles y usos de los mismos. | |
| EA199800140A1 (ru) | Композиции с контролируемым высвобождением пароксетина | |
| EA200970704A1 (ru) | ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ АНТАГОНИСТЫ NK1 РЕЦЕПТОРА И БЛОКАТОРЫ Na КАНАЛОВ | |
| DE60302157D1 (de) | Opioidrezeptorantagonisten | |
| ATE225349T1 (de) | Crf rezeptor-antagonisten und darauf bezogene methoden | |
| NO20025640D0 (no) | Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptor-antagonister | |
| EA200400280A1 (ru) | Новые неочищенные и кристаллические формы гидрохлорида лерканидипина | |
| CY1110572T1 (el) | Στοματικο αντικαταθλιπτικο σκευασμα το οποιο περιλαμβανει ακετυλοσαλικυλικο οξυ για επιταχυνση της εναρξης δρασης | |
| DK1673354T3 (da) | Arylindenopyridiner og arylindenopyrimidiner og deres anvendelse som adenosin-A2a-receptorantagonister | |
| NO20014855L (no) | N-(2-fenyl-4-aminobutyl)-1-naftamider som neurokinin-1- reseptorantagonister | |
| EA200500672A1 (ru) | Содержащие альфузозин композиции с отсроченным высвобождением | |
| AR030788A1 (es) | Antagonistas de receptores de taquiquinina zwitterionica | |
| NO20035148D0 (no) | Tri- og tetra-aza-acenaftylenderivater som CRF- reseptorantagonister | |
| ATE384066T1 (de) | Thieno-pyrrole verbindungen als antagonisten der gonadotropin-freisetzenden hormonrezeptoren | |
| MXPA05011476A (es) | Imidazolin-2-il-aminofenil-amidas como antagonistas de prostaglandina i2. | |
| MXPA02012029A (es) | Kit para reducir dolor continuo. | |
| DE60100811D1 (de) | Crf rezeptor-antagonisten und darauf bezogene methoden | |
| ATE260918T1 (de) | Crf rezeptor-antagonisten und darauf bezogene methoden | |
| HRP20090225T1 (hr) | Farmaceutske kompozicije na bazi nk2 antagonista za pedijatrijsku primjenu |